Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Dual MEK inhibitor IMM-1-104 may be an improvement over approved MEK inhibitors

Oct. 18, 2021

PRT-2527 shows efficacy in models of hematological and solid tumors with MYC dysregulation

Oct. 18, 2021

AstraZeneca synthesizes new cannabinoid CB1 receptor antagonists

Oct. 18, 2021

Gritscience Biopharmaceuticals identifies casein kinase 1 isoform delta inhibitors

Oct. 18, 2021

Janssen Pharmaceutica patents MGLL inhibitors

Oct. 18, 2021

PDAC priming boosts chemotherapeutic efficacy

Oct. 18, 2021

DeoBioSciences reports preclinical data on DBX-31 in advanced cancers

Oct. 15, 2021

Exelixis and Storm Therapeutics collaborate to advance novel drug leads for cancer

Oct. 15, 2021

IL-36gamma-based therapy modulates immune response in pancreatic cancer models

Oct. 15, 2021

IntoCell and Ab Studio establish research collaboration to combine antibody and linker capabilities

Oct. 15, 2021

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...